Please ensure Javascript is enabled for purposes of website accessibility

Here's Why Live Nation, TripAdvisor, and Middleby Stocks Are Soaring Today

By Anders Bylund – May 18, 2020 at 12:37PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Consumer-facing companies of all stripes are jumping as medical research company Moderna reported promising results in an early-stage coronavirus vaccine.

What happened

Many consumer-oriented stocks rose dramatically on Monday due to promising results from an early coronavirus vaccine trial. The news lifted stock prices across sector lines and industries as investors jumped to bullish conclusions. For example, travel services specialist TripAdvisor (TRIP -1.78%) traded 14.6% higher at 12:10 p.m. EDT, while Ticketmaster parent Live Nation Entertainment (LYV -2.85%) reached a peak gain of 18.3% 45 minutes earlier, and restaurant equipment maker Middleby (MIDD -1.02%) posted a  9.9% increase at 9.50 a.m. EDT.

So what

Quick access to an effective coronavirus vaccine would be great news for all of these companies.

  • Live Nation has closed down its events and ticket sales until further notice, raising $1.2 billion of new debt last week in order to keep the lights on until this crisis has passed.
  • TripAdvisor published 26% lower sales in the first quarter with an even weaker second-quarter outlook, because travel just isn't an option for most people these days. Daily trip bookings plunged 90% in late March and all of April.
  • Fast-food restaurants with drive-through windows are doing alright, but sit-down dining chains are suffering in this climate. Take-out orders and home delivery options can't make up for lost sales at the premises, and you won't find most restaurant chains making investments in their food preparation equipment anytime soon. Kitchen equipment sales could drop as much as 85% this year, according to short-selling market analyst Prescience Point Capital Management, spelling doom for sector leader Middleby.

Operating under these Swords of Damocles, investors are looking for any sign of progress toward a solid vaccine, an effective treatment method for active COVID-19 cases, or any other event that would open the world to normal operations again. Today's positive trial results from coronavirus vaccine researcher Moderna (MRNA -0.55%) is a good example of investors looking for signs of normality.

A doctor holds up a small earth model to the camera.

Image source: Getty Images.

Now what

Moderna's study results are promising, but we're still a long way away from having a safe and effective coronavirus vaccine for everybody. The company hopes to start a larger phase 3 trial in July if all goes well in the phase 2 study that is currently under way, followed by an accelerated FDA filing. In the best of all possible worlds, Moderna might be able to start producing the vaccine in early 2021.

So we're far from getting back to anything near last year's number of rock concerts, travel bookings, and sit-down restaurant meals. Middleby, Live Nation, and TripAdvisor have many months of rocky road ahead, even if Moderna (or other hopeful coronavirus vaccine developers) comes up aces in the upcoming level 3 trials.

That's why today's strong jumps fell far short of a full recovery. Live Nation is still trading 40% below January's all-time highs, Middleby's stock sits 55% below its 52-week peak prices, and TripAdvisor's investors are still nursing a 59% drop from last July's full-year zenith. I wouldn't be surprised to see them give up their recent gains based on negative COVID-19 reports along the way. Handle these fragile tickers with care until we actually have an effective vaccine available for everybody.

Selim Bassoul, former CEO, chairman, and president of Middleby, serves as Chief Innovator at The Motley Fool. Anders Bylund has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Live Nation Entertainment, Middleby, and TripAdvisor. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

TripAdvisor, Inc. Stock Quote
TripAdvisor, Inc.
TRIP
$22.06 (-1.78%) $0.40
The Middleby Corporation Stock Quote
The Middleby Corporation
MIDD
$126.85 (-1.02%) $-1.31
Live Nation Entertainment, Inc. Stock Quote
Live Nation Entertainment, Inc.
LYV
$75.27 (-2.85%) $-2.21
Moderna, Inc. Stock Quote
Moderna, Inc.
MRNA
$123.64 (-0.55%) $0.68

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
329%
 
S&P 500 Returns
106%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 09/24/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.